Throat-nose swab there, gargle there – testing was daily fare in the corona peak. A biotech company from Upper Austria specializes in the development of rapid tests. A procedure must now be used to help all the hospital’s outpatient clinics: mobile mini-laboratories determine the risk of death from a drop of blood in 20 minutes.
It all started with a technology that detects hospital bacteria and their resistance to antibiotics. In the pandemic, the company Genspeed Biotech attracted attention with a rapid lab-quality test that analyzed antibodies against Covid-19 and could even determine whether someone had had corona in the past. Now the company from Rainbach im Mühlkreis (Upper Austria) is attracting attention twice.
Source: Krone
I’m Ben Stock, a journalist and author at Today Times Live. I specialize in economic news and have been working in the news industry for over five years. My experience spans from local journalism to international business reporting. In my career I’ve had the opportunity to interview some of the world’s leading economists and financial experts, giving me an insight into global trends that is unique among journalists.
